Replimune Group, Inc.
NASDAQ:REPL
5.895 (USD) • At close September 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 3.502 | 2.655 | 2.447 | 4.575 | 4.139 | 1.807 | 0.148 | 0.109 | 0.122 |
| Gross Profit
| -3.502 | -2.655 | -2.447 | -4.575 | -4.139 | -1.807 | -0.148 | -0.109 | -0.122 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 189.447 | 174.963 | 126.527 | 79.545 | 56.754 | 38.761 | 22.173 | 13.516 | 6.936 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 23.201 | 17.437 | 8.773 | 5.713 | 2.711 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 72.18 | 59.81 | 50.553 | 38.769 | 23.201 | 17.437 | 8.773 | 5.713 | 2.711 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | -3.084 | 0.451 | -2.056 | 0.626 |
| Operating Expenses
| 261.627 | 234.773 | 177.08 | 118.314 | 79.955 | 53.114 | 28.418 | 16.962 | 8.205 |
| Operating Income
| -261.627 | -234.773 | -177.08 | -118.314 | -79.955 | -56.198 | -30.946 | -19.229 | -9.647 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 14.798 | 19.387 | 3.084 | 0.278 | -0.915 | 3.573 | 0.112 | -0.473 | 1.943 |
| Income Before Tax
| -246.829 | -215.386 | -173.996 | -118.036 | -80.87 | -52.625 | -30.834 | -19.702 | -7.704 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.468 | 0.408 | 0.288 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -247.297 | -215.794 | -174.284 | -118.036 | -80.87 | -52.625 | -30.834 | -19.702 | -7.704 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -3.07 | -3.24 | -2.99 | -2.26 | -1.75 | -1.54 | -1.33 | -0.64 | -0.36 |
| EPS Diluted
| -3.07 | -3.24 | -2.99 | -2.26 | -1.75 | -1.54 | -1.33 | -0.64 | -0.25 |
| EBITDA
| -261.627 | -230.198 | -170.303 | -114.408 | -76.478 | -52.597 | -28.27 | -16.853 | -8.083 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |